Cargando…
Immune vulnerability of ovarian cancer stem-like cells due to low CD47 expression is protected by surrounding bulk tumor cells
Recurrence of advanced epithelial ovarian cancer is common despite optimal surgical debulking and initial favorable responses to chemotherapy. Evidences suggest that cancer stem cells (CSCs) have inherent resistance to conventional therapies such as chemotherapy and play a decisive role in cancer re...
Autores principales: | Chang, Chih-Long, Wu, Chao-Chih, Hsu, Yun-Ting, Hsu, Yi-Chiung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7458642/ https://www.ncbi.nlm.nih.gov/pubmed/32923164 http://dx.doi.org/10.1080/2162402X.2020.1803530 |
Ejemplares similares
-
Expression and Significance of CD44, CD47 and c-met in Ovarian Clear Cell Carcinoma
por: Wang, Huimin, et al.
Publicado: (2015) -
Engineered CAR-T cells targeting TAG-72 and CD47 in ovarian cancer
por: Shu, Runzhe, et al.
Publicado: (2021) -
Significance of CD47 and Its Association With Tumor Immune Microenvironment Heterogeneity in Ovarian Cancer
por: Yu, Lan, et al.
Publicado: (2021) -
Regulation of CD47 expression in cancer cells
por: Huang, Can-Yu, et al.
Publicado: (2020) -
CD47 promotes ovarian cancer progression by inhibiting macrophage phagocytosis
por: Liu, Ran, et al.
Publicado: (2017)